Capture saponin fractions enhancing the vaccine potency
Expertise in the fractioning of specific saponin fractions presenting an immunological profile of interest for a determined antigen or pathogen.
Proof of concept formulation
Q-VANT’s capabilities allow the formulation and development of prototypes of adjuvants systems including saponins, as well as the combination with other adjuvants to improve the safety profile and the potency of the adjuvant.
Exploratory studies
Q-VANT offers the exploratory evaluation of vaccines incorporating saponin-based adjuvants and specific antigens in post-vaccination immunity and pre-clinical infection models. The experiments are conducted via a third party laboratory following ICLAS guideline with AAALAC accreditation.
Adjuvant screening
Q-VANT expertise allow to conduct the screening of distinct saponin adjuvants for the optimum immune response with specific antigens against the targeted disease.
